Generation and characterization of a novel anti-rat CD40L antibody with inhibitory activities in vitro and in vivo

Journal of Immunological Methods

Volumn 335, Issue 1-2, 2008, Pages 46-52

  Stax, Annelein M ^a   Gelderman, Kyra A ^a   Kamerling, Sylvia W A ^a   van der Geest, Reinier ^a   Schlagwein, Nicole ^a   van Kooten, Cees ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antigen presentation; Blocking antibody; CD40; CD40L; Rat

Indexed keywords

CD40 LIGAND; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY AS1; OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD40; B-LYMPHOCYTES; CD40 LIGAND; CELLS, CULTURED; CRICETINAE; CRICETULUS; CYTOKINES; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FIBROBLASTS; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; MALE; MICE; OVALBUMIN; RATS; RATS, INBRED LEW; T-LYMPHOCYTES; TIME FACTORS; TRANSFECTION;

CRICETULUS MIGRATORIUS; MURINAE; RATTUS;

EID: 43149112311     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2008.02.013     Document Type: Article

References (21)

1. Baxter A.G., and Hodgkin P.D. Activation rules: the two-signal theories of immune activation. Nat. Rev., Immunol. 2 (2002) 439
2. Durie F.H., Fava R.A., Foy T.M., Aruffo A., Ledbetter J.A., and Noelle R.J. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 261 (1993) 1328
3. Fishbein T.M., Wang L., Benjamin C., Liu J., Tarcsafalvi A., Leytin A., Miller C.M., and Boros P. Successful tolerance induction under CD40 ligation in a rodent small bowel transplant model: first report of a study with the novel antibody AH.F5. Transplantation 73 (2002) 1943
4. Foy T.M., Shepherd D.M., Durie F.H., Aruffo A., Ledbetter J.A., and Noelle R.J. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J. Exp. Med. 178 (1993) 1567
5. Gerritse K., Laman J.D., Noelle R.J., Aruffo A., Ledbetter J.A., Boersma W.J., and Claassen E. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 2499
6. Gravestein L.A., Nieland J.D., Kruisbeek A.M., and Borst J. Novel mAbs reveal potent co-stimulatory activity of murine CD27. Int. Immunol. 7 (1995) 551
7. Grewal I.S., and Flavell R.A. A central role of CD40 ligand in the regulation of CD4+ T-cell responses. Immunol. Today 17 (1996) 410
8. Hamann J., van Zeventer C., Bijl A., Molenaar C., Tesselaar K., and van Lier R.A. Molecular cloning and characterization of mouse CD97. Int. Immunol. 12 (2000) 439
9. Kirk A.D., Harlan D.M., Armstrong N.N., Davis T.A., Dong Y., Gray G.S., Hong X., Thomas D., Fechner Jr. J.H., and Knechtle S.J. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 8789
10. Lenschow D.J., Walunas T.L., and Bluestone J.A. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14 (1996) 233
11. Mackey M.F., Barth Jr. R.J., and Noelle R.J. The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells. J. Leukoc. Biol. 63 (1998) 418
12. Mohan C., Shi Y., Laman J.D., and Datta S.K. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J. Immunol. 154 (1995) 1470
13. Monk N.J., Hargreaves R.E., Marsh J.E., Farrar C.A., Sacks S.H., Millrain M., Simpson E., Dyson J., and Jurcevic S. Fc-dependent depletion of activated T cells occurs through CD40L-specific antibody rather than costimulation blockade. Nat. Med. 9 (2003) 1275
14. Nathan M.J., Yin D., Eichwald E.J., and Bishop D.K. The immunobiology of inductive anti-CD40L therapy in transplantation: allograft acceptance is not dependent upon the deletion of graft-reactive T cells. Am. J. Transplant. 2 (2002) 323
15. Salomon B., and Bluestone J.A. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu. Rev. Immunol. 19 (2001) 225
16. Sebille F., Brouard S., Petzold T., Degauque N., Guillet M., Moreau A., Benjamin C.D., and Soulillou J.P. Tolerance induction in rats, using a combination of anti-CD154 and donor splenocytes, given once on the day of transplantation. Transplantation 75 (2003) 169
17. Tomasoni S., Azzollini N., Casiraghi F., Capogrossi M.C., Remuzzi G., and Benigni A. CTLA4Ig gene transfer prolongs survival and induces donor-specific tolerance in a rat renal allograft. J. Am. Soc. Nephrol. 11 (2000) 747
18. van Kooten C., and Banchereau J. CD40-CD40 ligand. J. Leukoc. Biol. 67 (2000) 2
19. Waldmann H. The new immunosuppression: just kill the T cell. Nat. Med. 9 (2003) 1259
20. Woltman A.M., van der Kooij S.W., de Fijter J.W., and van Kooten C. Maturation-resistant dendritic cells induce hyporesponsiveness in alloreactive CD45RA+ and CD45RO+ T-cell populations. Am. J. Transplant. 6 (2006) 2580
21. Yuan X., Dong V.M., Coito A.J., Waaga A.M., Salama A.D., Benjamin C.D., Sayegh M.H., and Chandraker A. A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection. Transplantation 73 (2002) 1736